198 related articles for article (PubMed ID: 26210676)
1. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis.
Carvalho AF; Köhler CA; McIntyre RS; Knöchel C; Brunoni AR; Thase ME; Quevedo J; Fernandes BS; Berk M
Psychoneuroendocrinology; 2015 Dec; 62():18-26. PubMed ID: 26210676
[TBL] [Abstract][Full Text] [Related]
2. Role of trophic factors GDNF, IGF-1 and VEGF in major depressive disorder: A comprehensive review of human studies.
Sharma AN; da Costa e Silva BF; Soares JC; Carvalho AF; Quevedo J
J Affect Disord; 2016 Jun; 197():9-20. PubMed ID: 26956384
[TBL] [Abstract][Full Text] [Related]
3. Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis.
Shi Y; Luan D; Song R; Zhang Z
Eur Neuropsychopharmacol; 2020 Dec; 41():40-51. PubMed ID: 32980240
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of vascular endothelial growth factor in patients with major depressive disorder: A meta-analysis.
Tseng PT; Cheng YS; Chen YW; Wu CK; Lin PY
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1622-30. PubMed ID: 26123242
[TBL] [Abstract][Full Text] [Related]
5. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis.
Dinoff A; Herrmann N; Swardfager W; Gallagher D; Lanctôt KL
J Psychiatr Res; 2018 Oct; 105():123-131. PubMed ID: 30219561
[TBL] [Abstract][Full Text] [Related]
6. The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder.
Amidfar M; Réus GZ; de Moura AB; Quevedo J; Kim YK
Adv Exp Med Biol; 2021; 1305():257-272. PubMed ID: 33834404
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
Pu J; Liu Y; Gui S; Tian L; Xu S; Song X; Zhong X; Chen Y; Chen X; Yu Y; Liu L; Zhang H; Wang H; Zhou C; Zhao L; Xie P
Psychiatry Res; 2020 Oct; 292():113319. PubMed ID: 32717712
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.
Qin XY; Wu HT; Cao C; Loh YP; Cheng Y
Mol Psychiatry; 2017 Sep; 22(9):1306-1312. PubMed ID: 28070123
[TBL] [Abstract][Full Text] [Related]
9. BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.
Polyakova M; Stuke K; Schuemberg K; Mueller K; Schoenknecht P; Schroeter ML
J Affect Disord; 2015 Mar; 174():432-40. PubMed ID: 25553404
[TBL] [Abstract][Full Text] [Related]
10. Adipokines as emerging depression biomarkers: a systematic review and meta-analysis.
Carvalho AF; Rocha DQ; McIntyre RS; Mesquita LM; Köhler CA; Hyphantis TN; Sales PM; Machado-Vieira R; Berk M
J Psychiatr Res; 2014 Dec; 59():28-37. PubMed ID: 25183029
[TBL] [Abstract][Full Text] [Related]
11. Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses.
Kishi T; Yoshimura R; Ikuta T; Iwata N
Front Psychiatry; 2017; 8():308. PubMed ID: 29387021
[TBL] [Abstract][Full Text] [Related]
12. Vascular Endothelial Growth Factor: a potential diagnostic biomarker for major depression.
Clark-Raymond A; Meresh E; Hoppensteadt D; Fareed J; Sinacore J; Halaris A
J Psychiatr Res; 2014 Dec; 59():22-7. PubMed ID: 25193461
[TBL] [Abstract][Full Text] [Related]
13. Association of Peripheral Blood Levels of Brain-Derived Neurotrophic Factor With Autism Spectrum Disorder in Children: A Systematic Review and Meta-analysis.
Qin XY; Feng JC; Cao C; Wu HT; Loh YP; Cheng Y
JAMA Pediatr; 2016 Nov; 170(11):1079-1086. PubMed ID: 27654278
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders.
Lee BH; Kim YK
J Affect Disord; 2012 Jan; 136(1-2):181-184. PubMed ID: 21862441
[TBL] [Abstract][Full Text] [Related]
15. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Çakici N; Sutterland AL; Penninx BWJH; Dalm VA; de Haan L; van Beveren NJM
Brain Behav Immun; 2020 Aug; 88():547-558. PubMed ID: 32330592
[TBL] [Abstract][Full Text] [Related]
16. Imaging genetics paradigms in depression research: Systematic review and meta-analysis.
Pereira LP; Köhler CA; Stubbs B; Miskowiak KW; Morris G; de Freitas BP; Thompson T; Fernandes BS; Brunoni AR; Maes M; Pizzagalli DA; Carvalho AF
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():102-113. PubMed ID: 29778546
[TBL] [Abstract][Full Text] [Related]
17. Potential value of serum brain-derived neurotrophic factor, vascular endothelial growth factor, and S100B for identifying major depressive disorder in knee osteoarthritis patients.
Zhang P; Xiong Y; Wang B; Zhou Y; Wang Z; Shi J; Li C; Lu X; Chen G
Front Psychiatry; 2022; 13():1019367. PubMed ID: 36386998
[TBL] [Abstract][Full Text] [Related]
18. Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?
Arosio B; Guerini FR; Voshaar RCO; Aprahamian I
Front Behav Neurosci; 2021; 15():626906. PubMed ID: 33643008
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.
Brunoni AR; Lopes M; Fregni F
Int J Neuropsychopharmacol; 2008 Dec; 11(8):1169-80. PubMed ID: 18752720
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor in patients with schizophrenia: A systematic review and meta-analysis.
Misiak B; Stramecki F; Stańczykiewicz B; Frydecka D; Lubeiro A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():24-29. PubMed ID: 29772306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
